Andrographis — Research Profile

Andrographis has arguably stronger clinical evidence than echinacea, with a Cochrane review of 33 RCTs supporting its use for cold symptoms ^[2]. The effect sizes in andrographis trials tend to be larger and more consistent. Andrographis is better for treatment of active colds, while echinacea may be slightly better for prevention. They can be combined — the Kan Jang formula actually combines andrographis with Eleutherococcus (Siberian ginseng). Andrographis is much more bitter in taste.

Andrographis is one of the most intensely bitter plants used in medicine, and its bitter taste is legendary in Ayurvedic and Chinese traditional practice. The bitterness comes primarily from andrographolide and related diterpenoid lactones. In traditional medicine, bitterness was considered therapeutically important, stimulating digestive secretions and liver function. For modern supplementation, capsules are strongly recommended unless you have a tolerance for extremely bitter flavors.

Short-term use (5-14 days) for acute illness has the best safety data. Long-term safety data is more limited. Animal studies have shown anti-fertility effects at high doses, so andrographis is not recommended during pregnancy or for those trying to conceive. For daily preventive use, lower doses (200-300mg) and periodic cycling (8 weeks on, 2 weeks off) are prudent approaches until more long-term human data is available.

The best form of andrographis depends on your specific health goals, absorption needs, and tolerance. Chelated and standardized extract forms generally offer higher bioavailability than raw or unstandardized versions. Check the product label for third-party testing to ensure potency and purity.

Andrographis has been studied for multiple health applications with varying levels of clinical evidence. The strongest evidence typically comes from randomized controlled trials and meta-analyses published in peer-reviewed journals. Individual responses can vary based on baseline status, dosage, and duration of use.

Andrographis dosage depends on the specific form, your health goals, and individual factors such as body weight and baseline nutrient status. Following the dose used in clinical trials is generally the most evidence-based approach. Starting at the lower end of the recommended range and adjusting upward is advisable.

Andrographis timing depends on whether it is fat-soluble or water-soluble and whether it causes digestive sensitivity. Consistency in timing is more important than the specific hour of the day. Taking supplements at the same time daily helps maintain steady levels.

Andrographis is generally well tolerated at recommended doses, with gastrointestinal discomfort being the most commonly reported side effect. Side effects are typically mild and dose-dependent, resolving with dose reduction or taking with food. Serious adverse effects are rare at standard supplemental doses.

Andrographis may interact with certain prescription medications by affecting absorption, metabolism, or pharmacological effects. Always inform your healthcare provider about all supplements you take, especially before surgery or when starting new medications. Spacing supplements and medications by 2 hours reduces most absorption interactions.

Andrographis is most appropriate for individuals with confirmed deficiency, suboptimal levels, or specific health conditions supported by clinical evidence. People in higher-risk demographics, including older adults and those with restricted diets, may benefit most. Testing baseline levels before supplementing provides the best guidance.

Andrographis effects vary by the specific health outcome being targeted, with some benefits appearing within days and others requiring weeks to months of consistent daily use. Correcting a deficiency typically shows improvement within 2-4 weeks. A minimum 8-12 week trial at the recommended dose is advisable before evaluating effectiveness.

Andrographis is considered safe for long-term use at recommended doses based on available clinical data. Staying within established upper intake limits minimizes the risk of adverse effects over time. Periodic reassessment with a healthcare provider is recommended, especially if health conditions change.

Exceeding the recommended dose of andrographis increases the risk of adverse effects without providing additional benefit. Toxicity risk varies by form and individual factors such as kidney and liver function. Mega-dosing is not supported by clinical evidence and should be avoided.

Andrographis can generally be combined with complementary supplements, though some combinations may affect absorption or create additive effects. Spacing different supplements by 1-2 hours can reduce absorption competition. Consulting a healthcare professional is advisable when combining multiple supplements targeting the same health pathway.

Third-party testing from USP, NSF, or ConsumerLab is the most important quality indicator when purchasing andrographis supplements. Look for products that clearly state the specific form, dose per serving, and any relevant standardization percentages. Avoid proprietary blends that hide individual ingredient amounts.